Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity
Comparison in people · 2009
- What was studied
- 68 early-rehabilitation patients; 35 adjunctive Cortexin, 33 basic therapy
- Main finding
- Motor and cognitive outcomes favored adjunctive Cortexin over basic therapy during short follow-up.
Global-state improvement · 27/35 (77.1%) versus 18/33 (54.5%) · End of treatment
Reported findings and study design
68 stroke rehabilitation patients: Cortexin 35 versus basic treatment 33; age 60.5 ± 2.8 years. Add-on Cortexin 10 mg IM daily for ten days.
Population or model 68 early-rehabilitation patients; 35 adjunctive Cortexin, 33 basic therapy
Dose, route and schedule
Cortexin: 10 mg intramuscularly daily for 10 days, added to basic treatment during early ischemic-stroke rehabilitation. Controls received basic treatment alone.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Global-state improvement | 27/35 (77.1%) versus 18/33 (54.5%) | End of treatment |
| Motor/cognitive rehabilitation comparison | Cortexin favored | p<0.05 |
| Treatment adverse effects | None observed in this small comparison |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Allocation and masking are unclear in the abstract.
- Short follow-up and limited safety reporting do not establish sustained independence or safety.
Source details
Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.
Abstract reviewed
Sources checked
Citation
Nurguzhaev ES, Mitrokhin DA, Izbasarova ASh, Nurguzhaev AE, Raimkulov BN, Abdil'manova BR. Use of cortexin in the early rehabilitation period of ischemic stroke of moderate severity Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 19672239